March 9, 2020 / 6:37 PM / a month ago

BRIEF-FDA Approves Ofev Oral Capsules As First Treatment For Group Of Progressive Interstitial Lung Diseases

March 9 (Reuters) - FDA:

* FDA APPROVES OFEV (NINTEDANIB) ORAL CAPSULES AS FIRST TREATMENT FOR GROUP OF PROGRESSIVE INTERSTITIAL LUNG DISEASES

* FDA - GRANTED APPROVAL OF OFEV TO TREAT ILD WITH A PROGRESSIVE PHENOTYPE TO BOEHRINGER INGELHEIM PHARMACEUTICALS Source text: (bit.ly/3aDUewK) Further company coverage: [ ]

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below